Medicus Pharma Financials
| MDCX Stock | 3.99 0.01 0.25% |
Short Ratio 0.96 | EPS Estimate Current Year (1.50) | EPS Estimate Current Quarter (0.11) |
Medicus | Select Account or Indicator |
Please note, the imprecision that can be found in Medicus Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medicus Pharma. Check Medicus Pharma's Beneish M Score to see the likelihood of Medicus Pharma's management manipulating its earnings.
Medicus Pharma Stock Summary
Medicus Pharma competes with Highwood Asset, Western Investment, Doman Building, Westshore Terminals, and Magna Mining. Medicus Pharma is entity of Canada. It is traded as Stock on V exchange.| Foreign Associate | USA |
| Instrument | Canada Stock View All |
| Exchange | TSX Venture Exchange |
| Business Address | 100 King Street |
| Benchmark | Dow Jones Industrial |
You should never invest in Medicus Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medicus Stock, because this is throwing your money away. Analyzing the key information contained in Medicus Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Medicus Pharma Key Financial Ratios
There are many critical financial ratios that Medicus Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medicus Pharma reports annually and quarterly.| Net Income | (6.78 M) | |||
| Total Asset | 1.89 M | |||
| Retained Earnings | (19.18 M) |
Medicus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medicus Pharma's current stock value. Our valuation model uses many indicators to compare Medicus Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicus Pharma competition to find correlations between indicators driving Medicus Pharma's intrinsic value. More Info.Medicus Pharma is regarded fourth in current valuation category among its peers. It is rated below average in shares outstanding category among its peers creating about 0.30 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Medicus Pharma is roughly 3.39 . Common Stock Shares Outstanding is likely to drop to about 17.7 M in 2025. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicus Pharma's earnings, one of the primary drivers of an investment's value.Medicus Pharma Systematic Risk
Medicus Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medicus Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Medicus Pharma correlated with the market. If Beta is less than 0 Medicus Pharma generally moves in the opposite direction as compared to the market. If Medicus Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medicus Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medicus Pharma is generally in the same direction as the market. If Beta > 1 Medicus Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Medicus Pharma Total Assets Over Time
Medicus Pharma January 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medicus Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medicus Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medicus Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Medicus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medicus Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 18.58 | |||
| Information Ratio | 0.0109 | |||
| Maximum Drawdown | 129.29 | |||
| Value At Risk | (10.77) | |||
| Potential Upside | 14.43 |
Additional Tools for Medicus Stock Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.